# A Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer

Source: https://onco.cc/trials/nct07805551/  
OnCo record `nct07805551` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of HDM2017, Bevacizumab, CAPOX in colorectal cancer, run by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., now recruiting.

## Summary

A Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer is a phase 1/2 interventional study registered as NCT07805551 by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., with 220 participants planned, started 2026-08-18 and due to reach its primary completion in 2030-08. Interventions recorded: HDM2017, Bevacizumab, Oxaliplatin, Fluorouracil, Capecitabine. Conditions listed: CRC, Colorectal Cancer. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT07805551
- Phase: 1/2
- Setting: A Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HDM2017 Combination Therapy in Participants With Advanced Colorectal Cancer
- Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Enrolled: 220

## Sources

- ClinicalTrials.gov NCT07805551: https://clinicaltrials.gov/study/NCT07805551

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)
- drugs: [Bevacizumab](https://onco.cc/drugs/bevacizumab/), [Capecitabine](https://onco.cc/drugs/capecitabine/), [CAPOX (capecitabine, oxaliplatin)](https://onco.cc/drugs/capox/), [FLOT (5-FU, leucovorin, oxaliplatin, docetaxel)](https://onco.cc/drugs/flot/), [Fluorouracil (5-FU)](https://onco.cc/drugs/fluorouracil/), [HDM2017](https://onco.cc/drugs/hdm2017/)

---
JSON: https://onco.cc/api/v1/entities/nct07805551.json